About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Midazolam Additive to Local Anesthetic in Peribulbar Block

NCT03397069·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Al Jedaani Hospital

Age

40–70

Sex

ALL

Healthy volunteers

Accepted

You may be eligible if

90 adult patients with ASA physical status I to III
Aged 40-70 years
Scheduled for elective extracapsular or phacoemulsification cataract surgery with peribulbar block
No history of allergy to local anesthetics
Axial length less than 28 mm.

You may not be if

Patient's refusal to share in the study
communication barrier (e.g. impaired hearing, disturbed conscious level, impaired mental status)
uncontrolled tremors
morbidly obese patients
allergy to lidocaine
coagulation abnormalities
glaucoma
recent surgical procedure on the same eye.

The record

StatusCompleted

PhaseNo phase

Taking part90

StartedJan 2018

UpdatedAug 14, 2018

Conditions

Postoperative Pain Cataract Local Anaesthetic Complication Midazolam

Where1

Al Jedaani group of hospitals
Jeddah, Meccah, Saudi Arabia

Clareo Health | Midazolam Additive to Local Anesthetic in Peribulbar Block